Rivastigmine
symptomatic treatment of Alzheimer's disease
Nothing to addBy the Layer Nutrition editorial team · How the atlas classifies the 664 molecules
What this medicine is for
Pharmacologically, Rivastigmine relates to the category “symptomatic treatment of Alzheimer's disease”. This treatment aims to slow or ease certain symptoms of Alzheimer's disease.
For Rivastigmine, in practice: Symptomatic treatment of Alzheimer's disease. It is generally taken over the long term, within regular monitoring, and is not stopped on your own initiative.
Under which brands it is found
In France, about 13 reimbursable presentations containing Rivastigmine are recorded. It comes under various trade names and in generic form.
- Exelon
- Rivastigmine Arrow
- Rivastigmine Biogaran
- Rivastigmine Sandoz
- Rivastigmine Viatris
- Rivastigmine Eg Labo
- Rivastigmine Zentiva
- and other presentations
Original brand-name products and generics deliver the same active substance; the choice between them is made with your doctor or pharmacist.
Do you need a supplement? No.
For Rivastigmine, we offer no supplement. No nutritional supplementation is seriously justified as an addition to this treatment, and we would rather write that than invent a need. Our range is limited to five classes of everyday medicines for which a targeted intake makes sense; outside of those, we do not sell for the sake of selling, and that is what gives weight to our five products.
Related molecules
To explore in the « Neurology and mind » family and its neighbours.
See the whole « Neurology and mind » family · Back to the atlas